Current Treatment Options in Oncology

Papers
(The TQCC of Current Treatment Options in Oncology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective65
Angiosarcoma: Role of Immunotherapy55
Family Meetings in Palliative Care: Benefits and Barriers52
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome51
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma49
Role of Virus-Directed Therapy in Soft Tissue Sarcoma43
Targeted Therapies in Low-Grade Serous Ovarian Cancers40
Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases39
Strategies to Assess and Manage Frailty among Patients Diagnosed with Primary Malignant Brain Tumors37
Modern Management of Gastric Neuroendocrine Neoplasms36
Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast Cancer36
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission35
Role of Metastasis-Directed Therapy in Genitourinary Cancers35
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma33
Approach to Patients with High-Risk Localized Prostate Cancer: Radiation Oncology Perspective31
The Intersection of Prostate Cancer and Hypertension: a Call to Action31
Immunotherapy in the Fight Against Bone Metastases: A Review of Recent Developments and Challenges30
Correction to: Cardiotoxicity of Systemic Melanoma Treatments29
An Update on the Management of Rectal Neuroendocrine Neoplasms29
Correction to: Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer28
Updates in Treatment of HER2-positive Metastatic Breast Cancer27
HER2-Directed Therapy in Advanced Gastric and Gastroesophageal Adenocarcinoma: Triumphs and Troubles25
“When Less is More”: Paradigm Shifts in Radiation Treatment for Early-Stage Breast Cancer25
How to Sequence Therapies in Waldenström Macroglobulinemia24
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic24
The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors24
Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma22
Options for the Treatment of Mucinous Ovarian Carcinoma22
Leiomyosarcoma: Does Location of Primary Help to Determine the Best Systemic Therapy Options?22
The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer21
Nectin-4: a Novel Therapeutic Target for Skin Cancers21
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)20
Targeted Therapy for Melanomas Without BRAF V600 Mutations20
The Current Landscape of Research Advocacy and Education for Patients with Colorectal Cancer20
Myxoid Liposarcomas: Systemic Treatment Options19
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus19
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies19
Role of Stereotactic Radiation Therapy in Operable and Inoperable Early-Stage Non-small Cell Lung Cancer19
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead19
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect19
The Role of Induction Therapy for Sinonasal Cancers18
Guidance for Treating the Older Adults with Colorectal Cancer18
Opioid-induced Neurotoxicity in Patients with Cancer Pain17
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia17
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer17
Research Progress on Pyroptosis in Hematological Malignancies17
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer17
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?17
An Update on Temporal Bone Paragangliomas17
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes17
Tailoring Treatment for Patients with Inflammatory Breast Cancer17
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors16
Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer16
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer16
Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma16
The Role of SIRT1 in Leukemia16
Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations16
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management16
Trimodality Treatment of Extremity Soft Tissue Sarcoma: Where Do We Go Now?15
Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer15
Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?15
Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer15
Taxane-Associated Acute Pain Syndrome: a Review of its Features and Management14
Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome14
Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review14
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy14
Advances in PSMA-Targeted Radionuclide Therapeutics14
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy14
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity14
Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma14
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?14
Can Immune Therapy Cure Acute Myeloid Leukemia?14
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light13
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies13
Multidisciplinary Management of Brain Metastases from Non-Small Cell Lung Cancer in the Era of Immunotherapy13
Tarlatamab-dlle: A New Hope for Patients with Extensive-Stage Small-Cell Lung Cancer13
Recent Advances in Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor Systemic Therapies13
HER2-Positive Metastatic Colorectal Cancer13
Treatment Landscape of Renal Cell Carcinoma13
COVID-19 and Gynecologic Oncology: What Have We Learned?13
Advancements in Melanoma Therapies: From Surgery to Immunotherapy13
Metastatic Hormone–Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy12
Systemic Therapy for Metastatic Pancreatic Cancer12
Neoadjuvant Immunotherapy in Non-melanoma Skin Cancers of the Head and Neck12
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma12
A Review of Current and Future Antibody Drug Conjugates in Breast Cancer12
Dermatofibrosarcoma Protuberans in Children12
Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas12
Evolving Landscape of HER2-Targeted Therapies for Gastric Cancer Patients12
The Role of Nursing in the Delivery of Cardio-Oncology12
Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies12
Efficacy and Mechanism of Combining Radiotherapy and Immunotherapy in Stage IV Non-Small Cell Lung Cancer12
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia12
Targeted Therapy for BRAF Mutant Brain Tumors12
Therapeutic Management of Malignant Wounds: An Update12
Therapeutic Cancer Vaccines for Nonmelanoma Skin Cancer11
Current Management Options for Dyspnea in Cancer Patients11
Small Cell Lung Cancer—An Update on Chemotherapy Resistance11
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance11
Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant Treatment11
Desmoid Tumors: Current Perspective and Treatment11
Surgery Matters: Progress in Surgical Management of Gastric Cancer11
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?11
Targeting Angiogenic Factors for the Treatment of Medulloblastoma11
Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer10
Correction to: Voluntary Assisted Dying/Euthanasia: Will This Have an Impact on Cancer Care in Future Years?10
Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review10
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer – An Overview10
Ovarian Suppression: Early Menopause and Late Effects10
Pioneering the Way: The Revolutionary Potential of Antibody–Drug Conjugates in NSCLC10
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?10
Extent of Resection and Outcomes of Patients with Primary Malignant Brain Tumors10
From Subtypes to Solutions: Integrating CMS Classification with Precision Therapeutics in Colorectal Cancer10
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy10
External Beam Radiotherapy in the Management of Uveal Melanoma10
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials10
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming10
4.2823050022125